Cabotegravir (IMAGE)

Rockefeller University

Cabotegravir

Caption

The new drug cabotegravir (in vials above) has been shown to protect monkeys from infection by an HIV-like virus, and a clinical trial testing cabotegravir's safety and acceptability has begun. Unlike other preventive treatments, it would require only one injection every three months.

Credit

Zach Veilleux / The Rockefeller University

Usage Restrictions

Image may be used only to illustrate the research described in the accompanying story.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.